Synklino A/S
Public limited companyCVR 38778676København KActive
Synklino A/S is a public limited company, based in København K, active in research and experimental development on natural sciences and engineering, founded in 2017. The company made a loss in both 2024 and 2025, most recently DKK 17.2m. Equity fell to DKK 5.9m in 2025. 6 people are registered in the company's management and ownership.
Key figures · financial year 2025
Net profit−DKK 17.2m+67.3% vs. 2024
EquityDKK 5.9m−70.9% vs. 2024
Employees8latest month from CVR
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss got smaller: from DKK 52.5m to DKK 17.2m (2024 → 2025).
- Equity fell 71% (2024 → 2025), to DKK 5.9m.
Employees
- 1 more employees than a year earlier: 8 (07/2026) against 7 (07/2025).
Management and owners, last 24 months
- New in management: Herwig-Ulf Johannes Richard Meier-Kriesche (board member, 20/11/2025).
- New owners registered: Strategic Investments A/S (10/04/2026), Marie Rudkjær Schrøder ApS (10/04/2026) and Winther Schrøder Holding ApS (10/04/2026) (+3).
- No longer registered as owner: Marie Rudkjær Schrøder ApS (09/04/2026), Mette Marie Rosenkilde (03/03/2026) and Tnk Biotech ApS (03/03/2026) (+5).
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | not stated | not stated | not stated | not stated | not stated | – |
| Operating profit (EBIT) | −9,461 | −11,708 | −60,250 | −69,345 | −65,385 | −19,429 | +70.3% |
| Profit before tax | −12,030 | −12,683 | −63,049 | −67,618 | −57,989 | −19,695 | +66% |
| Net profit | −10,588 | −10,822 | −57,549 | −62,118 | −52,489 | −17,162 | +67.3% |
| Total assets | 14,482 | 104,700 | 171,712 | 109,154 | 34,255 | 13,827 | −59.6% |
| Equity | −12,500 | 88,843 | 145,746 | 86,835 | 20,210 | 5,879 | −70.9% |
| Liabilities | 26,982 | 15,857 | 25,966 | 22,319 | 14,045 | 7,948 | −43.4% |
| Cash and cash equivalents | 12,731 | 100,539 | 58,658 | 63,654 | 26,736 | 10,074 | −62.3% |
| Average number of employees | 4 | 5 | – | – | – | – | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 6 years in a row
Net result has been negative in 2020–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
Equity fell sharply
Equity fell 71% from 2024 to 2025 (DKK 20.2m to DKK 5.9m).
How is this calculated?
Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 28/05/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 10/07/2025 | The company | PDF not statedXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 18/06/2024 | The company | PDF not statedXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 23/05/2023 | The company | PDF not statedXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 22/06/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 28/06/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
EquityDKK 5.9mNo. 167 of 431
Better than 61% of the companies in the industry
Number of employees8No. 158 of 431
Better than 63% of the companies in the industry
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | not stated | No. 12,738of 69,964 Better than 82% |
| Same industry and fewer than 20 employees329 companies in the comparison | not stated | No. 87of 329 Better than 74% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | not stated | No. 5,429of 33,687 Better than 84% |
| All companies of type A/S18,025 companies in the comparison | not stated | No. 10,831of 18,024 Better than 40% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineeringGross profit
- Synklino A/S–
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
Net profit
- Synklino A/S−DKK 17.2m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
Equity
- Synklino A/SDKK 5.9m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
Employees
- Synklino A/S8
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership RegisterOwners
- Strategic Investments A/S10%
- Marie Rudkjær Schrøder ApS5%
- Winther Schrøder Holding ApS5%
Synklino A/S
Management
5 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Thomas Nitschke Kledal | CEO | 07/07/2017 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| John Sørensen Haurum | Chair of the board | 01/03/2019 |
| Mette Marie Rosenkilde | Board member | 01/03/2019 |
| Morten Winther Schrøder | Board member | 10/11/2021 |
| Herwig-Ulf Johannes Richard Meier-Kriesche | Board member | 20/11/2025 |
- Founders
- Mette Marie Rosenkilde, Mads Gravers Jeppesen, Tnk Biotech ApS
Former management (8)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Mads Aage Laustsen | Board member | 12/07/2018 | 22/05/2024 |
| Thomas Nitschke Kledal | Board member | 12/07/2018 | 29/09/2021 |
| Mette Marie Rosenkilde | Chair of the board | 12/07/2018 | 28/02/2019 |
| Thomas Feldthus | Board member | 29/09/2021 | 29/05/2024 |
| Lene Gerlach | Board member | 29/09/2021 | 29/09/2022 |
| Gunnar Magnus Severus Modée Persson | Board member | 29/09/2021 | 04/10/2024 |
| Mads Lacoppidan | Board member | 29/09/2022 | 03/10/2024 |
| Christine Flarup Møller-Jensen | Board member | 29/09/2022 | 02/10/2024 |
Signing rule: Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør, af 2 bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Address and production units
1 active production unitsFrederiksborggade 1
1360 København K
| Production unit | Address | Employees | P number |
|---|---|---|---|
| SYNKLINO A/S | Frederiksborggade 1, 2. th, 1360 København K | 8 | 1022631973 |
Purpose
Selskabets formål er at drive virksomhed med udvikling af lægemidler og hermed forbundet virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
95 registered events62017
142018
42019
32020
212021
122022
32023
142024
52025
132026
202613 changesaccounts 1 · ownership 12
- AccountsAnnual report for 2025 published
- OwnershipWinther Schrøder Holding ApS registered as owner (5%)
- OwnershipSTRATEGIC INVESTMENTS A/S registered as owner (10%)
- OwnershipMARIE RUDKJÆR SCHRØDER ApS registered as owner (5%)
- OwnershipSTRATEGIC INVESTMENTS A/S is no longer registered as owner
- OwnershipWinther Schrøder Holding ApS is no longer registered as owner
- OwnershipMARIE RUDKJÆR SCHRØDER ApS is no longer registered as owner
- OwnershipSTRATEGIC INVESTMENTS A/S registered as owner (10%)
- OwnershipWinther Schrøder Holding ApS registered as owner (5%)
- OwnershipTNK BIOTECH ApS is no longer registered as owner
- OwnershipSYNKLINO A/S is no longer registered as owner
- OwnershipMette Marie Rosenkilde is no longer registered as owner
- OwnershipSTRATEGIC INVESTMENTS A/S is no longer registered as owner
20255 changesmanagement 1 · ownership 2 · accounts 1 · industry 1
- ManagementHerwig-Ulf Johannes Richard Meier-Kriesche appointed board member
- OwnershipSTRATEGIC INVESTMENTS A/S registered as owner (5%)
- OwnershipSTRATEGIC INVESTMENTS A/S is no longer registered as owner
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
202414 changesownership 8 · management 5 · accounts 1
- OwnershipSTRATEGIC INVESTMENTS A/S registered as owner (0%)
- OwnershipTNK BIOTECH ApS registered as owner (0%)
- OwnershipSYNKLINO A/S registered as owner (33.33%)
- OwnershipMette Marie Rosenkilde registered as owner (0%)
- OwnershipMads Gravers Jeppesen registered as owner (0%)
- OwnershipDanmarks Eksport- og Investeringsfond is no longer registered as owner
- OwnershipMaj Invest Minorities I K/S is no longer registered as owner
- OwnershipEir Ventures I AB is no longer registered as owner
- ManagementGunnar Magnus Severus Modée Persson stepped down as board member
- ManagementMads Lacoppidan stepped down as board member
- ManagementChristine Flarup Møller-Jensen stepped down as board member
- AccountsAnnual report for 2023 published
- ManagementThomas Feldthus stepped down as board member
- ManagementMads Aage Laustsen stepped down as board member
20233 changesaccounts 1 · ownership 2
- AccountsAnnual report for 2022 published
- OwnershipDanmarks Eksport- og Investeringsfond registered as owner (5%)
- OwnershipVÆKSTFONDEN is no longer registered as owner
202212 changesmanagement 3 · address 1 · accounts 1 · capital 1 · ownership 6
- ManagementMads Lacoppidan appointed board member
- ManagementChristine Flarup Møller-Jensen appointed board member
- ManagementLene Gerlach stepped down as board member
- AddressMoved to Frederiksborggade 1, 2. th, 1360 København K
- AccountsAnnual report for 2021 published
- CapitalShare capital changed from 400,000 DKK to 680,117 DKK
- OwnershipMaj Invest Minorities I K/S registered as owner (25%)
- OwnershipEir Ventures I AB registered as owner (5%)
- OwnershipStichting Marcus Choleva Family Foundation is no longer registered as owner
- OwnershipMette Marie Rosenkilde is no longer registered as owner
- OwnershipTNK BIOTECH ApS is no longer registered as owner
- OwnershipSTRATEGIC INVESTMENTS A/S is no longer registered as owner
202121 changesname 1 · capital 1 · management 5 · ownership 12 · accounts 1 · address 1
- NameName changed from SYNKLINO ApS to SYNKLINO A/S
- CapitalShare capital changed from 59,418 DKK to 400,000 DKK
- ManagementMorten Winther Schrøder appointed board member
- OwnershipStichting Marcus Choleva Family Foundation registered as owner (5%)
- OwnershipMette Marie Rosenkilde registered as owner (5%)
- OwnershipVÆKSTFONDEN registered as owner (5%)
- OwnershipMR BIOINVEST ApS registered as owner (15%)
- OwnershipMR BIOINVEST ApS is no longer registered as owner
- OwnershipTNK BIOTECH ApS registered as owner (5%)
- OwnershipSTRATEGIC INVESTMENTS A/S registered as owner (5%)
- OwnershipMARIE RUDKJÆR SCHRØDER ApS registered as owner (5%)
- OwnershipMads Gravers Jeppesen is no longer registered as owner
- OwnershipMR BIOINVEST ApS is no longer registered as owner
- OwnershipMette Marie Rosenkilde is no longer registered as owner
- OwnershipTNK BIOTECH ApS is no longer registered as owner
- ManagementLene Gerlach appointed board member
- ManagementGunnar Magnus Severus Modée Persson appointed board member
- ManagementThomas Feldthus appointed board member
- ManagementThomas Nitschke Kledal stepped down as board member
- AccountsAnnual report for 2020 published
- AddressMoved to Rådhusvej 13, 2920 Charlottenlund
20203 changescapital 1 · ownership 2
- CapitalShare capital changed from 54,412 DKK to 59,418 DKK
- OwnershipMR BIOINVEST ApS registered as owner (10%)
- OwnershipMR BIOINVEST ApS is no longer registered as owner
20194 changesaddress 1 · management 3
- AddressMoved to Ole Maaløes Vej 3, 2200 København N
- ManagementJohn Sørensen Haurum appointed chair of the board
- ManagementMette Marie Rosenkilde appointed board member
- ManagementMette Marie Rosenkilde stepped down as chair of the board
201814 changesaddress 1 · name 1 · capital 1 · management 3 · ownership 8
- AddressMoved to Asylgade 7A, 2800 Kgs. Lyngby
- NameName changed from SYNKLINO IVS to SYNKLINO ApS
- CapitalShare capital changed from 25,000 DKK to 54,412 DKK
- ManagementMette Marie Rosenkilde appointed chair of the board
- ManagementMads Aage Laustsen appointed board member
- ManagementThomas Nitschke Kledal appointed board member
- OwnershipMette Marie Rosenkilde registered as owner (25%)
- OwnershipTNK BIOTECH ApS registered as owner (33.33%)
- OwnershipMR BIOINVEST ApS registered as owner (5%)
- OwnershipMads Gravers Jeppesen registered as owner (20%)
- OwnershipThomas Nitschke Kledal is no longer registered as owner
- OwnershipMette Marie Rosenkilde is no longer registered as owner
- OwnershipTNK BIOTECH ApS is no longer registered as owner
- OwnershipMads Gravers Jeppesen is no longer registered as owner
20176 changesfounded 1 · management 1 · ownership 4
- FoundedRegistered as SYNKLINO IVS
- ManagementThomas Nitschke Kledal appointed ceo
- OwnershipMette Marie Rosenkilde registered as owner (33.33%)
- OwnershipTNK BIOTECH ApS registered as owner (33.33%)
- OwnershipMads Gravers Jeppesen registered as owner (25%)
- OwnershipThomas Nitschke Kledal registered as owner (33.33%)
Related companies
Same industry in København
- Genmab A/S676 employees
- 3shape A/S518 employees
- Carlsberg A/S107 employees
- IQVIA RDS Denmark A/S100 employees
- Nuevolution A/S100 employees
- Sunshine Enterprise Holding A/S73 employees
Same people in management
- AGC Biologics A/Svia Mads Aage Laustsen
- Lenus eHealth ApSvia Mads Lacoppidan
- Dawn Health A/Svia Mads Lacoppidan
- Bioneer A/Svia Mads Aage Laustsen
- Xo Care A/Svia Morten Winther Schrøder
- Corti ApSvia Mads Lacoppidan
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.